Biocon Biologics to offer 15 pc stake to Serum Institute Life Sciences at valuation of USD 4.9 bn

Biocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about USD 4.9 billion.

WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.